Friday, April 10, 2026 8:07:47 AM
Current Price 3.77
Market Cap 239.606M
Market Cap 239.606M
Recent MGNX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:22:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:13:31 PM
- MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation • GlobeNewswire Inc. • 05/13/2026 08:01:00 PM
- GMP Manufacturing Sale Gives MacroGenics Additional Non-Dilutive Capital for Pipeline Development (MGNX) • IH Market News • 05/12/2026 03:08:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 12:00:15 PM
- MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals • GlobeNewswire Inc. • 05/11/2026 09:20:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:02:06 PM
- MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement • GlobeNewswire Inc. • 05/04/2026 11:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:45:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2026 08:41:59 PM
- FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study • GlobeNewswire Inc. • 04/08/2026 08:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/08/2026 08:02:26 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/08/2026 08:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 08:12:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/09/2026 08:10:34 PM
- MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures • GlobeNewswire Inc. • 03/09/2026 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 09:15:28 PM
- MacroGenics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/26/2026 10:30:00 PM
- MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial • GlobeNewswire Inc. • 02/23/2026 11:14:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/18/2026 02:47:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:27:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:26:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:25:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:23:49 PM
